Short Interest in Arbor Rapha Capital Bioholdings Corp. I (NASDAQ:ARCK) Decreases By 46.7%

Arbor Rapha Capital Bioholdings Corp. I (NASDAQ:ARCKGet Rating) was the recipient of a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 2,400 shares, a drop of 46.7% from the October 15th total of 4,500 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 63,800 shares, the days-to-cover ratio is presently 0.0 days.

Arbor Rapha Capital Bioholdings Corp. I Stock Performance

Shares of NASDAQ:ARCK opened at $10.26 on Friday. Arbor Rapha Capital Bioholdings Corp. I has a 52-week low of $9.84 and a 52-week high of $10.61. The business has a 50-day moving average price of $10.16 and a 200-day moving average price of $10.10.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Elequin Capital LP purchased a new position in Arbor Rapha Capital Bioholdings Corp. I during the third quarter valued at approximately $25,000. Robinson Capital Management LLC purchased a new position in Arbor Rapha Capital Bioholdings Corp. I during the second quarter valued at approximately $205,000. Landscape Capital Management L.L.C. purchased a new position in Arbor Rapha Capital Bioholdings Corp. I during the third quarter valued at approximately $214,000. Omni Event Management Ltd purchased a new position in Arbor Rapha Capital Bioholdings Corp. I during the first quarter valued at approximately $441,000. Finally, Glazer Capital LLC purchased a new position in Arbor Rapha Capital Bioholdings Corp. I during the first quarter valued at approximately $470,000. 71.63% of the stock is currently owned by hedge funds and other institutional investors.

Arbor Rapha Capital Bioholdings Corp. I Company Profile

(Get Rating)

Arbor Rapha Capital Bioholdings Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar Business Combination with one or more businesses. It intends to identify acquisition opportunities in the biopharmaceutical sector.

Featured Stories

Receive News & Ratings for Arbor Rapha Capital Bioholdings Corp. I Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arbor Rapha Capital Bioholdings Corp. I and related companies with MarketBeat.com's FREE daily email newsletter.